Weight Management
Who Is a Candidate for GLP-1 Medications?
October 8, 2026 Vitality Medicine RX Editorial Team
FDA-approved GLP-1 medications for weight management are for adults with a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition such as hypertension, type 2 diabetes or high cholesterol, when used together with a reduced-calorie diet and increased physical activity. Candidacy is not decided by BMI alone: medical history, medications and goals all matter. Vitality Medicine RX offers nurse practitioner-led telehealth weight-management care in states where Dr. Miklos Major II, Sc.D., DNP, NP-BC, FAAMFM holds an active license.
The FDA-approved criteria
FDA-approved GLP-1 medications for chronic weight management are indicated for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition, always in combination with a reduced-calorie diet and increased physical activity.
What weight-related conditions count
- Hypertension
- Type 2 diabetes or prediabetes
- Dyslipidemia, such as high cholesterol
- Obstructive sleep apnea
- Other weight-related conditions, depending on the specific medication
What professional guidelines say
The Endocrine Society and the American Gastroenterological Association recommend considering pharmacotherapy, together with lifestyle intervention, for adults with a BMI of 30 or higher, or 27 or higher with weight-related complications, who have not achieved enough with lifestyle change alone.
Why evaluation comes first
Before any prescription, evaluation reviews your medical history, current medications, thyroid, kidney, pancreas and gallbladder history, and appropriate labs. Contraindications, such as a personal or family history of medullary thyroid carcinoma, are checked. This is not a checklist: the plan is built around your specific situation.
What candidacy does not mean
Meeting the criteria does not guarantee a specific result, and these medications are not a substitute for nutrition, activity and sustainable habits. They are one tool, used when appropriate, with ongoing monitoring.
When to talk to a clinician
If you are wondering whether you qualify, book a discovery call. We will confirm we can see you in your state and review whether a GLP-1 medication may be appropriate for you.
Sources
- FDA: Approval of Zepbound (tirzepatide) for chronic weight management
- FDA: Approval of Wegovy (semaglutide) for chronic weight management
- Endocrine Society: Pharmacological Management of Obesity clinical practice guideline
- AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity
Related Pages
Talk to a Clinician
This article is educational and does not replace individualized medical advice. If you have questions about your own health, book a discovery call with Vitality Medicine RX. Your care is led by Dr. Miklos Major II, Sc.D., DNP, NP-BC, FAAMFM, a Doctor of Nursing Practice (DNP) and Doctor of Science (Sc.D.), board-certified nurse practitioner (NP-BC). Care is available in states where he holds an active license.
Book a Discovery CallQuestions About This Topic
What BMI qualifies for GLP-1 medications?
A BMI of 30 or higher, or 27 or higher with at least one weight-related condition, per the FDA-approved indications for these medications.
Can I take a GLP-1 if I am not overweight?
The FDA-approved indications are for adults with overweight or obesity. These are not approved for cosmetic weight loss.
Do I need labs before starting?
Yes. Evaluation typically includes metabolic, kidney, liver and thyroid labs plus a review of your history, medications and risk factors.
How do I know if I qualify?
Book a discovery call. We will confirm your state, review your history and goals, and outline the evaluation steps.
Last updated 2026-10-08.